+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Allogeneic bone marrow transplantation in severe combined immunodeficiency

Allogeneic bone marrow transplantation in severe combined immunodeficiency

Immunitaet und Infektion 13(6): 245-248

Bone marrow transplantation (BMT) represents the therapy of choice in severe combined immunodeficiency (SCID). Besides a short description of the clinical picture and of the diagnostical criteria of the disorder, the basis and results of BMT in SCID are presented. This treatment can result in the complete immunological reconstitution with resulting cure of affected patients. Recently, the use of other than HLA-identical marrow donors has become possible, such as haploidentical parents. Threatening complications from graft versus host disease are preventable by depleting T-cells from marrow grafts. Early results of this new approach are very encouraging, and represent significant advance in clinical BMT.

(PDF emailed within 1 workday: $29.90)

Accession: 004699111

Download citation: RISBibTeXText

Related references

Telomere Length after Allogeneic Bone Marrow Transplantation in Children with Severe Combined Immunodeficiency Disease. Blood 100(11): Abstract No 2414, November 16, 2002

Chimerism and immune reconstitution following allogeneic bone marrow transplantation for severe combined immunodeficiency disease. Immunodeficiency 4(1-4): 311-313, 1993

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency. Blood 97(3): 809-811, 2001

Successful treatment of systemic cytomegalovirus infection in severe combined immunodeficiency using allogeneic bone marrow transplantation followed by adoptive immunotherapy. Journal of Investigational Allergology & Clinical Immunology 24(3): 200-202, 2014

The use of locus-specific minisatellite probes to check engraftment following allogeneic bone marrow transplantation for severe combined immunodeficiency disease. Bone Marrow Transplantation 5(3): 199-204, 1990

Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. Blood 84(11): 3936-3947, 1994

Cooperation between donor t cells and host b cells and monocytes after allogeneic bone marrow transplantation for severe combined immunodeficiency. Journal of Allergy & Clinical Immunology 77(1 PART 2): 191, 1986

Allogeneic bone marrow transplantation for active Epstein-Barr virus-related lymphoproliferative disease and hemophagocytic lymphohistiocytosis in an infant with severe combined immunodeficiency syndrome. Bone Marrow Transplantation 29(6): 519-521, 2002

Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency. Journal of Pediatrics 134(6): 740-748, 1999

Bone marrow transplantation in severe combined immunodeficiency from a sibling who had received a paternal bone marrow transplant. New England Journal of Medicine 335(24): 1811-1814, 1996

Successful bone marrow transplantation of children with X-linked severe combined immunodeficiency using bone marrow depleted of T-cells by centrifugal elutriation. Journal of Cellular Biochemistry Supplement 0(18B): 72, 1994

Successful bone marrow transplantation in 2 patients with severe combined immunodeficiency using soybean agglutinin lectin and okt 3 pretreated non identical unrelated bone marrow. Experimental Hematology (Charlottesville) 12(SUPPL 15): 89-90, 1984

Epidermodysplasia verruciformis (EV) after bone marrow transplantation for the treatment of severe combined immunodeficiency: a model to understand the specific immunodeficiency of EV?. Annales de Dermatologie et de Venereologie 118(11): 847-850, 1991

Allogeneic bone marrow transplantation in severe combined immune defects (SCID). Immunitat und Infektion 13(6): 245-248, 1985

Treatment of severe thrombasthenia combined with pyknodysostosis by allogeneic bone marrow transplantation. Onkologie 14(SUPPL 2): 153, 1991